Motesanib diphosphate
Motesanib (AMG-706), is an orally bioavailable multiple-receptor tyrosine kinase inhibitor with potential antineoplastic activity. Motesanib selectively targets and inhibits vascular endothelial growth factor (VEGFR), platelet-derived growth factor (PDGFR), kit, and Ret receptors, thereby inhibiting angiogenesis and cellular proliferation.
Product Specifications
Shipping Conditions
gel pack
Storage Conditions
-20°C
Shelf Life
36 months
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS2164642-01 0.1 mL
PE-Linked Monoclonal Antibody to Cluster Of Differentiation 164 (CD164)
Sign In for Pricing
View Details MBS2164642-02 0.2 mL
PE-Linked Monoclonal Antibody to Cluster Of Differentiation 164 (CD164)
Sign In for Pricing
View Details MBS2164642-03 0.5 mL
PE-Linked Monoclonal Antibody to Cluster Of Differentiation 164 (CD164)
Sign In for Pricing
View Details 
MBS2164642-04 1 mL
PE-Linked Monoclonal Antibody to Cluster Of Differentiation 164 (CD164)
Sign In for Pricing
View Details 
MBS2164642-05 5 mL
PE-Linked Monoclonal Antibody to Cluster Of Differentiation 164 (CD164)
Sign In for Pricing
View Details MBS2164642-06 5x 5 mL
PE-Linked Monoclonal Antibody to Cluster Of Differentiation 164 (CD164)
Sign In for Pricing
View Details